`0’,
`
`1A.011// ,a.
`
`2,”,M,
`,
`
`”w”.
`a.(1%
`III/11110,
`
`V1111”,III/III
`
`,,:1./
`
`MARSHA A. ROSE
`DIRECTOR
`
`(202] 772-8692
`MROSE@SKGF.COM
`
`February 13, 2012
`
`Commissioner for Patents
`
`PO Box 1450
`
`Alexandria, VA 22313 - l 450
`
`Re:
`
`US. Non-Provisional Utility Patent Application under 37 C.F.R. § 1.53(b)
`(Continuation oprpl. No. 12/526,296; § 3 71(c) Date: January 13, 2011)
`Appl. N0. To be assigned; Filed: Herewith
`For:
`Treatment for Multiple Sclerosis (As Amended)
`Inventors: LUKASHEV et al.
`
`Our Ref: 2159.3210002/JMC/MRG/U-S
`
`Sir:
`
`The following documents are transmitted herewith for appropriate action by the US.
`Patent and Trademark Office:
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`Utility Patent Application Transmittal Form (PTO/SB/OS);
`
`Online Credit Card Payment Authorization for $6,480.00 to cover:
`
`$1,250.00 Patent Application fees (including basic filing, search, and
`examination fees);
`
`$4,800.00 Prioritized Examination Fee;
`
`$300.00 Publication Fee; and
`
`$130.00 Processing Fee.
`
`Certification and Request for Prioritized Examination Under 37 CPR.
`§ 1.102(e);
`
`Authorization to Treat a Reply As Incorporating An Extension of Time
`Under 37 C.F.R. § 1.136(a)(3);
`
`US. Utility Patent Application entitled:
`
`Treatment for Multiple Sclerosis (As Amended)
`
`and naming as inventors:
`
`
`
`Biogen Exhibit 2016
`
`Mylan V. Biogen
`IPR2018-01403
`;\ k m :‘v x. m N:
`
`Biogen Exhibit 2016
`Mylan v. Biogen
`IPR2018-01403
`
`Page 1 of 5
`
`

`

`Commissioner for Patents
`
`February 13, 2012
`Page 2
`
`Matvey E. LUKASHEV and Gilmore O'NEILL
`
`the application consisting of:
`
`a.
`
`b.
`
`c.
`
`d.
`
`e.
`
`An Application Data Sheet (37 C.F.R. § 1.76);
`
`Copy of an executed combined Declaration and Power of Attorney
`filed in US. Application No. 12/526,296;
`
`A specification containing:
`
`i.
`
`ii.
`
`34 pages of description prior to the claims;
`
`3 pages of claims (17 claims);
`
`iii.
`
`a one (1) page abstract;
`
`4 sheets of drawings (Figures 1-4); and
`
`Sequence listing;
`
`Request for Transfer of a Computer Readable Form Under 37 C.F.R.
`§ 1.821(e);
`
`Preliminary Amendment Under 37 C.F.R. § 1.115;
`
`Authorization to Permit Access to Application by Participating Offices
`(PTO/SB/39);
`
`Information Disclosure Statement (IDS);
`
`IDS Form PTO/SB/O8a (1 page);
`
`First Supplemental Information Disclosure Statement;
`
`First Supplemental IDS Form PTO/SB/08a (7 pages);
`
`First Supplemental IDS Form PTO/SB/08b (30 pages);
`
`Second Supplemental Information Disclosure Statement;
`
`Second Supplemental IDS Forén PTO/SB/08a (1 page);
`
`Second Supplemental IDS Form PTO/SB/08b (4 pages);
`
`Third Supplemental Information Disclosure Statement; and
`
`6.
`
`7.
`
`8.
`
`9.
`
`10.
`
`11.
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`Page 2 0f 5
`
`Page 2 of 5
`
`

`

`Commissioner for Patents
`
`February 13, 2012
`Page 3
`
`18.
`
`IDS Form PTO/SB/O8b
`Third Supplemental
`accompanying documents (NPL328-NPL336).
`
`(1
`
`page) with
`
`9
`
`The above-listed documents arefiled electronically through EFS- Web.
`
`Fee payment is provided through online credit card payment. The US. Patent and
`Trademark Office is hereby authorized to charge any fee deficiency, or credit any overpayment,
`to our Deposit Account No. 19-003 6.
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & Fox P.L.L.C.
`
`
`
`Marsha A. Rose
`
`Attorney for Applicants
`Registration No. 58,403
`
`MRG/U—S :enm
`
`Enclosures
`
`1474804_1.DOCX
`
`
`H
`
`Page‘3 0f5
`
`
`
`
`
`\\\\\\‘\\
`
`Page 3 of 5
`
`

`

`
`Equivalent of Form PTO/SBJOBa (07-09)Wumnxww‘m
`
` y
`Complete if Known
`
`
`......,...,.......,.,.,.,.,.............~..4... . A “team“...W ,,,,,, w.on“A...\E.»..\........-.EV VV.. VV.
`3_To beassigned
`Ac IlicationNumber
`
`..Flllnm“W. ‘Herewith
`INFORMATIDN DISCLOSURE
`
`
`
`iFirstNamed Inventor
`Matve’E LIH<AHSWH~E~VMW.
`STATEMENT BY APPLICANT
`
`
`
`(Use as many sheets as necessary)
`._._\,_....\\.-....\::........E-_......4“a..........“.....‘
`
`
`
`To be asst.ned
`
`Examiner Name
`
`Sheet
`
`kw\\\~o~»~\
`
`\\\_\~5\\
`\\\N\\\\~.\\\\w~
`>>>>> mx\\\m\s\\\\\\\\\\~\V\V§V~\\V\~J\svasxxxvowaw
`
`Attorney Docket Number
`,
`
`
`21-593210002/JMC/MRG/U—S
`
`
`\vak\w~v~«~\\mv.sss~.~‘x
`\M\'\\-)im\\\\\\.;-x"\\\¢x\th‘.“\ihwsyw‘mem~~W~s\\\\~\\g\ .
`.\\z\\\«an
`
`
`
`u.s. PATENTS AND PUBLISHED u.s. PATENT APPL CATIONS
`“I
`L
`9
`WWW%WI\W\\X\%VXW\m\\\\w\\\\k\k\\m\sfi‘.\\XWW«N\\\“\~I~\\L\V\~VV\\M\.~\»\vrn»‘n»\\\l§‘v~'\\“\x\\ee\\nr
`(.x-a.‘X‘R\Kfioo(~s&«-v~ww
`,
`.
`.
`-.
`
`Examiner E are ;
`Documenl Number ..
`.
`Issue or
`E
`Name ofPaEenlea or
`§E
`Pages. Columns. Lines. Where
`‘3
`v
`E""““‘“ “M“‘Mx Publication Date
`Applicanf of Chad Document
`I
`Relevant Passe as or Relevant
`I
`lnlllals
`No.
`3
`
`I
`Figuresippear
`r
`2»
`NumberKind (.todea (Hkmm)
`§ MM.DD.YYYY
`i
`3
`xi}... M...
`u.5....._..V....m...................e.MWm...“....
`M...,.......V.M.....WV.M.MV....A.......-.r...:.m..-WA. ....
`MESWWVV.-.W..~..3
`E
`g US-
`‘
`I
`
`'§“~V....V....we}.w»m..§...,.m..m“...,--r..........._....._..
`_
`.r W;
`“m..-
`........W..
`
`w~\~n;.~~\s\«sw
`We..."..»~.»»<~..<.<<..M“.....\.\s\\e~.».~~-Aw.\.~.~.“~:.-.Eu“~«(‘“uv«Ran-«vnun-nun“«wnn-“v--.~*~-<--u-'.~.. \ \
`‘.
`E
`$ US—
`E
`
`us.
`‘ ‘
`g
`................\.~s...‘.mw-w..wm.mm\._mun... E
`.\.W.EV«a»...-W~M3WME.\ME.W Eu...“a...“u....... .VE..§“..,. . .. . .... -.V..VV_V ___._____V_VV.“‘. ..._ .__
`,
`
`, US—
`§
`.
`.. “x-..” -WIAmevuV..........
`.m...-.-..mw-
`
`. US-
`'3
`i
`WW‘WM’... .m
`.41.“EM...............M....-..mm“............I-
`‘USA
`3
`W:
`2
`~\§xfim~h~o~\»~\\\“M§\\A\\\\\.\\\\\‘m%\\<\~\“x\‘\%m\wm~m'o“x\\\\\V\\(\M«~M\\\\\WVKS\\‘\\\\‘\\\\\\\\\;.\\N51.3));{56\<~~)-\\Vvo‘».w»~sv~.\~«\w~~WfimxWm-x~~s~xsmm\‘\\\\sww
`Note Copies of the U. 3. Patent Documents are not RequiredEn IDS filed after October 21 2004
`
`\\\\\\‘A\\\\\\\\3\‘Ms\\\\\\(~tx x.“\\Vé-c\\\\)\\:‘¢
`
`\«w-WW.A-nuu<u;.-«E.~.\\x\»m...;\Helmi.av~\\xv\vxm~\\“\<\\x-.«Ez“.\nag.“«E~\~&~E~\\\e\m~a
`«
`FOREIGN PATENT DOCUMENTS
`§
`
`Publication Date I,
`Name a! Felonies or
`Che
`3
`.
`Pages, Columns. Lines.
`x...~....~.......w.w“......w.m.mm...“.N.Wm....mw§.u...«memmmmWWW“..N.M~.NM.E EMMA-Ex.“gem“...umww...
`u,
`Applicant aI Oiled Document Where Relevant Passages é
`E'ND-
`\
`Fm‘egg: Palenl Doc:amen!
`£- MM=DDEYYW
`
`MM“MM
`or Relevant Figures
`“E...“ “-V
`
`W
`
`
`‘
`We.-. VV,.......WAWEA......w...
`VA
`V
`County Code Number‘ Kine Codas {Known} i
`Apoear
`'
`\
`
`
`i
`1
`3W020071005879 A2
`g
`0141-2007‘“
`Q
`I
`\
`I
`I
`§WAA mm...
`,.E.E.-..E..§.V..........W
`,
`......,....«.V-.E...M....~w%mu..
`.....§.-......- . .....V.V w. .em».M.....§mwew.......w-w.w .. mum»... M
`
`
`
`
`.
`km... -WM... ..-..-WW....
`......VM.W,3..-....
`-W...
`I
`V,.......MW.............
`. “We... “elem.--
`I"I.
`
`
`—\\\~I40«~(\M\A-R\\m\\\ux\~l\\\\\\\\\\\\\1\\\~.\\.\'M\\‘ \\x“\xmxxxxxxxwwxsuwwwueés
`\hxxxwwmsxmw“»“wwmaeweexuw—x.“uxm\.““unjmfi«xxx“n...n...»...E..\~u\\\\~\~w
`.ew'\V\“~.\\\\\\\\w\v.m“m§§\‘\“\Rx-.n«xxxmnxx\“x\)w.»wwww~nmewm»-ww«mxmxu\v\\\m\\\\\\\\\\\\\\m~.-\\~v~«\s§~s\\\\w~\fimwxw\\\v\
`
`
`
`NON PATENT LITERATURE DOCUMENTS
`g
`M
`WWW-..“mu--.WM... m-..“ ..W.....w.........---w-s
`Include name of the author (in CAPITAL LETTERS), tille of the article (when appmprlate). title of the Elam : Trenelatlon
`Examiner“i Cite
`i
`
`No.‘
`(book. magazine. Ioumal. serial. symposium. catalog. etc.) daIe. page(s), volume—Issue number(s),
`,
`Initials
`
`
`.E...,I..E..‘I"m
`
`isher,
`and/or country where
`1
`we“-..A.-.
`35:2“We. WWW“... M-m.
`E an: acid esters for the ltealmenl o
`sclerosis: an open-label.
`
`
`
`, baselineEcontrolIed pilot study“. European Journal of Neurology vol. 13, no. 6, XP—002496537 pages 604-
`
`“w.“x.‘........._._u... ...“v...“
`..E.....E......E.
`
`u..........VWMW 610-(4‘4'162006 A...“
`WIERINCKX ET AL., ”Detoxication enzyme lndueers modify cytoklne producllon In at mixed glial cells,
`
`
`
`,,,a...«MW
`Journal of Neureimmunology, Elsevler Science Publishers BV, XX, vol. 166. no. 1'2, XPv005000427. pages
`2IJI. 4
`rii
`
`
`...........
`~E.EV.-...V\M
`132-143 (September 1. 2005}
`
`
`
`wesm“.ww..wm.-E..~.m......;.m.LE.
`
`
`“\‘xmm..«I“w“..«mmmemu“.ww»m\\w..3.»\-.~W\«~~w.~.«\w-a~x»~ae :-:-:\\\s\\\«\\\\\§u¢n\h\\\a-~v-~NV“
`5 Dale
`i Examiner
`
`I
`" Signature
`Considered
`S
`i-Ql‘uxkhxuuvnamvwfinnonAnMM-WMWM~wwxxv\Wn\‘\\\\\\\WQ§V~V~»WV\~\-WW\K~MMZ"\\\(Vxnvoauxmxxxm‘ave
`”\WW\EM\‘\\\\\\\\IA\\\~2I.\\|-‘m\\1‘<\
`
`IISubstitute for form l449/PT0
`
`Vxwywiyyit/ItxtixfixIQAw
`
` I
`I pMIr/uJI/xxzy‘wwxew”;
`
`::
`
`
`
`4IASKI
`
`Y
`
`II’m/mega
`
`
`
`
`
`,.-,;.;~.o,w.ww»»~»~
`
`
`
`,Ib»~»$»m¢£muioweal.“am...
`
`
`
`
`I i i
`
`Page 4 0f 5
`
`Page 4 of 5
`
`

`

`é Substitute for foITn i449/PTO
`
`3
`'3
`
`”Iv”m4,m;»”uz/xrw‘w
`
`
`
`
`Equivalent of ForrII PTO/SB/OBa (O7—09}
`Complete if Known
`‘
`‘ “WE
`
`.
`"""
`WW:T0W3
`_
`
`
`
`
`
`
`
`
`. FllmsxDate W,
`..W,,H...”
`,
`INFOIU‘IATIDN DISCLOSURE
`
` FirstNamedInventor......... Math».EMLUKAHELW
`STATEMENT BY APPLICANT
`(Use as many sheets as necessaty)
`
`
`
`2159.3210002/JMC/MRG/U—S
`
`
`Attorney booket Number ., off
`m.m...“.\........:....~..._......................
`“w...
`MUM-AW
`
`
`,
`,
`xx‘x's’xxxxnwmw“w Wmm
`oxux»W\m\\\\\\\\\xx\\\aw\m~v.xv.wVw\\\\~\~l~u.~\-~u.\\\m.~\-.\vn»s»z.>mma-\\“\\\\"\\‘
`3
`_ U.S. PATENTS AND PUBLISHED U.S. PATENT APPLICATIONS
`Ft}
`
`:3 18stor
`Document Number
`i
`Name ofPa2enlea or
`2
`Pages. Columns. Lines. Where
`
`
`
`
`
`“"“MWMWAWAE Publication Date
`3
`Applicant of Chad Document
`3
`Relevani Passages or Reievant
`a.1’.“.A.‘\\~\\\\s~\£\£\mmumsss\\~~\mmwu-\§(¢u(n..
`: MM-DDWYYY
`Number-[and code2 (Imam)
`Q
`Figurss Appear
`M.M..............A.-......WM...“MM. m.\......g.....mw,w H
`
`. I
`
`i
`
`31 : i 1.
`
`I.3I.
`
`“A.A...15V“v’v’v——\M¥HVHV\\V‘\~\~\NN‘VV‘N“\\>\\AN‘\«AMMM\VV\\\‘\\-u\\nfifi-u
`I1z
`
` ,mkwwmmma
`
`
`.
`US-
`
`A..~ȤA....._~~~~~-w~
`an»,
`M
`.,,,M,,,,,,
`
`
`“WA...“J L
`
`. A \A....zhmw.““‘».\;\um§\\““““\“§.%\\‘\““\\‘\%m\wmm-(\\\k‘\\\\\~\\t\'fi\\M\\\\\W\§\\\\\\\\\V\\\\\\\\\“N“‘“\‘\"‘F"N‘\‘MWMW~~WMWMV\NN\W\A‘\‘“M!\\
`Note: Copies of the U. 5. Patent Documents are not Required2n IDS filed after October 21 2004
` ’was“i\v.((‘\\\\\\‘\<x‘~:\’\xxxx\\\\\\\~‘."A...
`.4
`.‘h\\‘i\¥_\“};\\«u‘m’n’n'~\\\u\u\v\m~\\v~fi-\s~x\\-.:x\.\M“
`K\‘\\“‘\\\\\\\\\“‘n\\\\\
`..«W..Ww.wmw.
`~
`
`
`
`FOREIGN PATENT DOCUMENTS
`s
`
`
`6‘3
`'=\'~v«-§\\-m~§:mw\\\vna\\‘\\\wk\x1 '
`: :'
`_ mm“
`Wmmm-fx\fimmku\\vukmmwmW\W\\“\\\\\\\\VI‘\\\\\\\\I\\\V\\\\v‘\“\&\““‘\\\-N\M~I\M\A\|¢>~v\“w..-3.",
`5 Publication Date i
`Name of Paientee or
`ranslalion :
`g Examiner S Cite
`§
`Pages, Columns. Lines.
`3 Where Relevant Passages:;
`i;
`lniflals
`§ No.
`3
`Fmags: Pagani Doc:amen!
`E MM-DDvYYW § Applicant oi Oiled Document
`g
`:
`‘i
`‘
`I
`7
`:A
`I
`E
`i
`3‘
`'3
`\....._....me mmvm;
`A55
`ox Relevani Figures
`.
`
`5
`‘5.
`i5
`County Code mm: Kind Code (now) 3
`3
`5
`MW
`
`........
`.A A. ..
`..A...A.\...W.~_.~_...w..«....»......w.\..,.,.,.“um“...m...
`~.W.......‘....w.mww.uus...mm.-...mm...
`:.A
`
`
`
`
`[7
`0141-2007
`i
`:
`ll 3
`§WO 20071005879 A2
`i
`
`Axxx-s-Au\\‘\21 “mu“... -v.»«A.-».~..»“...“:.+WM..._.__»%,“»“« ,..._.-.»».A. .w.
`gym,“........‘7;
`u....A»$........»~W
`“as“...«fia.Ae-xwwwuvg-mems
`2
`I
`l
`z
`:
`3
`l
`LI
`a
`
`
`$2....W» ‘
`....A.2.~\‘.~.~.........
`A.........§...._..Wwwx§wuw...
`.:
`$
`
`wu-
`
`
`+_~~I~A-~A~I
`
`
`msmm“.\\\\V\\vx\\mwxx~\wm\xv~\n\w‘\\\\\“\“\l\m\\\\\‘\¥h\m\§\\i<\\\\\h\‘x.m-~w
`m
`:m
`VxV‘\\\V\\\\\\\\m§\mwm“m\\““\g\‘Ihm\\\m\p§x\\\‘\\)\\\v~\wv-\xfi“\WVs\hKV‘\Ns‘rxm\w\‘\\\n\\x\\\‘\\\\\\\\\\mxw»v~xxv~\vvv~v.‘w‘~~~~w~~~sv--s\‘v:_
`
`
`NON PATENT LITERATURE DOCUMENTS
`~\\\~\s\W\§MN~sW\A3\\-(\VE\.
`m“<<\\\xxxn\\.:‘--\‘\\\m\\\m~\
`Qs\m\\\\\‘fl“un-RN‘KM‘Q—‘kfifnfifi‘x‘w‘w
`\\\\\\)W~vm
`§~\\\s4§~\s\'i\s\\~\~\\~~~\\\&§&‘I\’\'~§~X\K\:w‘;\.A.
`
`Examingr Cite
`‘
`Include nameof the author (in CAPITAL LETTERS). tille ofthe ariicle (when appropriate) title of the Iain':_
`(book. magazine. journal serial. symposium. catalog. etc.) date. page(s) volume—issue numbercs).
`initials
`No.I
`E
`
`
`
`.
`PU9!IS.&e.rw.g:r.309/3£92293rme£
`bi.
`--..--..M.......
`
`
`
`
`
`
`{"é'CI-“IifiRIGK: ET AL., "Ora
`‘
`sclerosis: an open-label.
`2 3:1: acid estersfor the Ireatmenl o
`“WWW 5
`
`~
`g baselinmconirolwd pilotsiudy“. European JournalofNeurology vol.13. no.6,XP-002496537 pages 604-
`U U i
`
`i
`W“ ,..........
`610. (June 2006 ”MN“
`m“...
`
`i WIERINCKX. ET AL.. ”Detoxicatlon enzyme inducers modify cytokine production in
`9
`”A.A.“.A
`
`\.lwwz‘v‘xvxvnvmmkww\xt\ux\‘!llfiulwi~6~§\\\1~........,
`§ Journal of Neurommunology, ElsevlerScIence Publishers BV, XX,vol. 166. no. 1~2, XP-005000427. pages
`.
`132-143 (September ‘_l 2005?
`.A.A.A.w.A.A.A......V‘va‘ssthM.t\\\\N~»~MM~m~«stw5\I35‘9”:...u,..................“A:
`
`WI
`
`\(“uxxx-A.iv...........A
`
`A.....A..WW“...NW...M.“WM.u.<.ww..“«g
`
`EEii f
`,i
`,s 2ifi z5 f ,iiiii 13i i5ii
`i?l’4i5,, , 23i
`
`
`
`
`
`
`wavy>.‘<<~vxwwmmm,, \\~W\\\\\\V\M_“xxnwxmwwxwww, , . -~~w-wwnw--xxvv ‘
`
`I
`.
`ZIN\‘\\\‘<«\\\\\\\\u\m\\\a\“~w~s\v\
`ww~xunxwmmm“\“u“mamwm. E
`05/62/2012
`D ‘B
`
`mkhun\afi\.\\.\m\:\m\‘xmw~sWW~nrn.\.\v-\\\\>w\i\‘\\\\\~\Mfiw~v~wv~ux~xss\V‘-\W\x~mv~\s\\xt
`..
`Considered
`g Examiner
`[/3th U m/
`Viv-\.\\9\\\V\\\\‘wt‘x‘wmmxwmswn‘sxxx‘xxxN55~-\~\»,\>_‘>.
`talk“;km‘ure
`
`(
`
`
`
`lv”ma/[MM
`
`Page 5 0f 5
`
`Page 5 of 5
`
`